Senior insider sale
Chief Medical Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$148.9K
13.30K shares
What this filing means
KARLIN DANIEL plans to sell 13.30K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $148.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001104659-25-124863
Officer· Chief Medical Officer
Since Jan 2022
13.30K
Shares to sell
$148.9K
Approx. market value
5.60K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/26/2025
5.60KTotal acquired5.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/26/2025 | Restricted Stock Vesting Compensation | 5.60K | — |
| Total | 5.60K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.70K
Market value
$75.3K
9/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.60K
Market value
$73.6K
12/26/2025
Total
Units
13.30K
Value
$148.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/25/2025 | 7.70K | $75.3K | — | Completed |
| Planned — Approximate Date | ||||
12/26/2025 | 5.60K | $73.6K | NASDAQ | Planned |
| Total | 13.30K | $148.9K | ||